Industry: Medical Devices & Consumables
Published Date: 2026-01-09
Pages: 129 Pages
Report ld: 5619937
Request Sample
Customized Report
Aortic and Peripheral Vascular Interventional Devices Market Size(US$)

CAGR 2026-2032
12.3%
Market Size,2032
USD 178,410
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Aortic and Peripheral Vascular Interventional Devices market was valued at US$ 80080 million in 2025 and is anticipated to reach US$ 178410 million by 2032, at a CAGR of 12.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Aortic and Peripheral Vascular Interventional Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
The North American market for Aortic and Peripheral Vascular Interventional Devices is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Aortic and Peripheral Vascular Interventional Devices is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Aortic and Peripheral Vascular Interventional Devices include Boston Scientific, Abbott, Medtronic, Terumo, Nipro, B. Braun, Cook Medical, MicroPort, Lepu Medical, Jiwei Medical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Aortic and Peripheral Vascular Interventional Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Aortic and Peripheral Vascular Interventional Devices. The Aortic and Peripheral Vascular Interventional Devices market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Aortic and Peripheral Vascular Interventional Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Aortic and Peripheral Vascular Interventional Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Aortic and Peripheral Vascular Interventional Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Aortic and Peripheral Vascular Interventional Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Aortic and Peripheral Vascular Interventional Devices Market Overview
1.1 Product Definition
1.2 Aortic and Peripheral Vascular Interventional Devices by Type
1.2.1 Global Aortic and Peripheral Vascular Interventional Devices Market Value by Type: 2025 vs 2032
1.2.2 Aorta
1.2.3 Peripheral Blood Vessels
1.2.4 Coronary Blood Vessels
1.2.5 Cerebral Blood Vessels
1.3 Aortic and Peripheral Vascular Interventional Devices by Application
1.3.1 Global Aortic and Peripheral Vascular Interventional Devices Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Aortic and Peripheral Vascular Interventional Devices Market Size Estimates and Forecasts
1.4.1 Global Aortic and Peripheral Vascular Interventional Devices Revenue 2021–2032
1.4.2 Global Aortic and Peripheral Vascular Interventional Devices Sales 2021–2032
1.4.3 Global Aortic and Peripheral Vascular Interventional Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Aortic and Peripheral Vascular Interventional Devices Market Competition by Manufacturers
2.1 Global Aortic and Peripheral Vascular Interventional Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Aortic and Peripheral Vascular Interventional Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Aortic and Peripheral Vascular Interventional Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Aortic and Peripheral Vascular Interventional Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Aortic and Peripheral Vascular Interventional Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Aortic and Peripheral Vascular Interventional Devices, Product Types and Applications
2.7 Global Key Manufacturers of Aortic and Peripheral Vascular Interventional Devices, Date of Entry into the Industry
2.8 Global Aortic and Peripheral Vascular Interventional Devices Market Competitive Situation and Trends
2.8.1 Global Aortic and Peripheral Vascular Interventional Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Aortic and Peripheral Vascular Interventional Devices Players Market Share by Revenue
2.8.3 Global Aortic and Peripheral Vascular Interventional Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Aortic and Peripheral Vascular Interventional Devices Market Scenario by Region
3.1 Global Aortic and Peripheral Vascular Interventional Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Aortic and Peripheral Vascular Interventional Devices Sales by Region: 2021–2032
3.2.1 Global Aortic and Peripheral Vascular Interventional Devices Sales by Region: 2021–2026
3.2.2 Global Aortic and Peripheral Vascular Interventional Devices Sales by Region: 2027–2032
3.3 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Region: 2021–2032
3.3.1 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Region: 2021–2026
3.3.2 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Region: 2027–2032
3.4 North America Aortic and Peripheral Vascular Interventional Devices Market Facts & Figures by Country
3.4.1 North America Aortic and Peripheral Vascular Interventional Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Aortic and Peripheral Vascular Interventional Devices Sales by Country (2021–2032)
3.4.3 North America Aortic and Peripheral Vascular Interventional Devices Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aortic and Peripheral Vascular Interventional Devices Market Facts & Figures by Country
3.5.1 Europe Aortic and Peripheral Vascular Interventional Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Aortic and Peripheral Vascular Interventional Devices Sales by Country (2021–2032)
3.5.3 Europe Aortic and Peripheral Vascular Interventional Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aortic and Peripheral Vascular Interventional Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Aortic and Peripheral Vascular Interventional Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Aortic and Peripheral Vascular Interventional Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Aortic and Peripheral Vascular Interventional Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Aortic and Peripheral Vascular Interventional Devices Market Facts & Figures by Country
3.7.1 Latin America Aortic and Peripheral Vascular Interventional Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Aortic and Peripheral Vascular Interventional Devices Sales by Country (2021–2032)
3.7.3 Latin America Aortic and Peripheral Vascular Interventional Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aortic and Peripheral Vascular Interventional Devices Sales by Type (2021–2032)
4.1.1 Global Aortic and Peripheral Vascular Interventional Devices Sales by Type (2021–2026)
4.1.2 Global Aortic and Peripheral Vascular Interventional Devices Sales by Type (2027–2032)
4.1.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Market Share by Type (2021–2032)
4.2 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Type (2021–2032)
4.2.1 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Type (2021–2026)
4.2.2 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Type (2027–2032)
4.2.3 Global Aortic and Peripheral Vascular Interventional Devices Revenue Market Share by Type (2021–2032)
4.3 Global Aortic and Peripheral Vascular Interventional Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Aortic and Peripheral Vascular Interventional Devices Sales by Application (2021–2032)
5.1.1 Global Aortic and Peripheral Vascular Interventional Devices Sales by Application (2021–2026)
5.1.2 Global Aortic and Peripheral Vascular Interventional Devices Sales by Application (2027–2032)
5.1.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Market Share by Application (2021–2032)
5.2 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Application (2021–2032)
5.2.1 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Application (2021–2026)
5.2.2 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Application (2027–2032)
5.2.3 Global Aortic and Peripheral Vascular Interventional Devices Revenue Market Share by Application (2021–2032)
5.3 Global Aortic and Peripheral Vascular Interventional Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abbott Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Terumo
6.4.1 Terumo Company Information
6.4.2 Terumo Description and Business Overview
6.4.3 Terumo Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Terumo Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.4.5 Terumo Recent Developments/Updates
6.5 Nipro
6.5.1 Nipro Company Information
6.5.2 Nipro Description and Business Overview
6.5.3 Nipro Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Nipro Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.5.5 Nipro Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Company Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 B. Braun Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
6.7 Cook Medical
6.7.1 Cook Medical Company Information
6.7.2 Cook Medical Description and Business Overview
6.7.3 Cook Medical Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Cook Medical Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.7.5 Cook Medical Recent Developments/Updates
6.8 MicroPort
6.8.1 MicroPort Company Information
6.8.2 MicroPort Description and Business Overview
6.8.3 MicroPort Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 MicroPort Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.8.5 MicroPort Recent Developments/Updates
6.9 Lepu Medical
6.9.1 Lepu Medical Company Information
6.9.2 Lepu Medical Description and Business Overview
6.9.3 Lepu Medical Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Lepu Medical Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.9.5 Lepu Medical Recent Developments/Updates
6.10 Jiwei Medical
6.10.1 Jiwei Medical Company Information
6.10.2 Jiwei Medical Description and Business Overview
6.10.3 Jiwei Medical Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Jiwei Medical Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.10.5 Jiwei Medical Recent Developments/Updates
6.11 Asahi Intecc
6.11.1 Asahi Intecc Company Information
6.11.2 Asahi Intecc Description and Business Overview
6.11.3 Asahi Intecc Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Asahi Intecc Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.11.5 Asahi Intecc Recent Developments/Updates
6.12 Kaneka
6.12.1 Kaneka Company Information
6.12.2 Kaneka Description and Business Overview
6.12.3 Kaneka Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Kaneka Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.12.5 Kaneka Recent Developments/Updates
6.13 Sino Medical
6.13.1 Sino Medical Company Information
6.13.2 Sino Medical Description and Business Overview
6.13.3 Sino Medical Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Sino Medical Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.13.5 Sino Medical Recent Developments/Updates
6.14 LifeTech
6.14.1 LifeTech Company Information
6.14.2 LifeTech Description and Business Overview
6.14.3 LifeTech Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 LifeTech Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.14.5 LifeTech Recent Developments/Updates
6.15 Gore
6.15.1 Gore Company Information
6.15.2 Gore Description and Business Overview
6.15.3 Gore Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Gore Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.15.5 Gore Recent Developments/Updates
6.16 Cordis
6.16.1 Cordis Company Information
6.16.2 Cordis Description and Business Overview
6.16.3 Cordis Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Cordis Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.16.5 Cordis Recent Developments/Updates
6.17 Acotec Scientific Holdings
6.17.1 Acotec Scientific Holdings Company Information
6.17.2 Acotec Scientific Holdings Description and Business Overview
6.17.3 Acotec Scientific Holdings Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Acotec Scientific Holdings Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.17.5 Acotec Scientific Holdings Recent Developments/Updates
6.18 Zylox-Tonbridge Medical Technology
6.18.1 Zylox-Tonbridge Medical Technology Company Information
6.18.2 Zylox-Tonbridge Medical Technology Description and Business Overview
6.18.3 Zylox-Tonbridge Medical Technology Aortic and Peripheral Vascular Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Zylox-Tonbridge Medical Technology Aortic and Peripheral Vascular Interventional Devices Product Portfolio
6.18.5 Zylox-Tonbridge Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aortic and Peripheral Vascular Interventional Devices Industry Chain Analysis
7.2 Aortic and Peripheral Vascular Interventional Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aortic and Peripheral Vascular Interventional Devices Production Mode & Process Analysis
7.4 Aortic and Peripheral Vascular Interventional Devices Sales and Marketing
7.4.1 Aortic and Peripheral Vascular Interventional Devices Sales Channels
7.4.2 Aortic and Peripheral Vascular Interventional Devices Distributors
7.5 Aortic and Peripheral Vascular Interventional Devices Customer Analysis
8 Aortic and Peripheral Vascular Interventional Devices Market Dynamics
8.1 Aortic and Peripheral Vascular Interventional Devices Industry Trends
8.2 Aortic and Peripheral Vascular Interventional Devices Market Drivers
8.3 Aortic and Peripheral Vascular Interventional Devices Market Challenges
8.4 Aortic and Peripheral Vascular Interventional Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Aortic and Peripheral Vascular Interventional Devices market is projected to grow from US$ 80080 million in 2025 to US$ 178410 million by 2032, at a CAGR of 12.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 173
USD 4900.00
(Single User License)
The global Aortic and Peripheral Vascular Interventional Devices market size was US$ 80080 million in 2025 and is forecast to reach a readjusted size of US$ 178410 million by 2032 with a CAGR of 12.3% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 101
USD 4250.00
(Single User License)
The global market for Aortic and Peripheral Vascular Interventional Devices was estimated to be worth US$ 80080 million in 2025 and is projected to reach US$ 178410 million, growing at a CAGR of 12.3% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 139
USD 3950.00
(Single User License)
The global Aortic and Peripheral Vascular Interventional Devices market is projected to grow from US$ 72100 million in 2024 to US$ 160620 million by 2031, at a CAGR of 12.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 180
USD 4900.00
(Single User License)
The global Aortic and Peripheral Vascular Interventional Devices market size was US$ 72100 million in 2024 and is forecast to a readjusted size of US$ 160620 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 108
USD 4250.00
(Single User License)
The global market for Aortic and Peripheral Vascular Interventional Devices was estimated to be worth US$ 72100 million in 2024 and is forecast to a readjusted size of US$ 160620 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 136
USD 3950.00
(Single User License)
The global market for Aortic and Peripheral Vascular Interventional Devices was valued at US$ 72100 million in the year 2024 and is projected to reach a revised size of US$ 160620 million by 2031, growing at a CAGR of 12.3% during the forecast period.
Published Date: 2025-03-10
Pages: 106
USD 2900.00
(Single User License)
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published Date: 2024-10-10
Pages: 175
USD 4900.00
(Single User License)
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published Date: 2024-10-10
Pages: 147
USD 4350.00
(Single User License)
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published Date: 2024-10-10
Pages: 103
USD 2900.00
(Single User License)
The global Aortic and Peripheral Vascular Interventional Devices market is projected to grow from US$ 80080 million in 2025 to US$ 178410 million by 2032, at a CAGR of 12.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 173
The global Aortic and Peripheral Vascular Interventional Devices market size was US$ 80080 million in 2025 and is forecast to reach a readjusted size of US$ 178410 million by 2032 with a CAGR of 12.3% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 101
The global market for Aortic and Peripheral Vascular Interventional Devices was estimated to be worth US$ 80080 million in 2025 and is projected to reach US$ 178410 million, growing at a CAGR of 12.3% from 2026 to 2032.
Published: 2026-01-09
Pages: 139
The global Aortic and Peripheral Vascular Interventional Devices market is projected to grow from US$ 72100 million in 2024 to US$ 160620 million by 2031, at a CAGR of 12.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 180
The global Aortic and Peripheral Vascular Interventional Devices market size was US$ 72100 million in 2024 and is forecast to a readjusted size of US$ 160620 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 108
The global market for Aortic and Peripheral Vascular Interventional Devices was estimated to be worth US$ 72100 million in 2024 and is forecast to a readjusted size of US$ 160620 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 136
The global market for Aortic and Peripheral Vascular Interventional Devices was valued at US$ 72100 million in the year 2024 and is projected to reach a revised size of US$ 160620 million by 2031, growing at a CAGR of 12.3% during the forecast period.
Published: 2025-03-10
Pages: 106
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published: 2024-10-10
Pages: 175
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published: 2024-10-10
Pages: 147
Medical instruments used for the diagnosis and treatment of aortic and peripheral vascular diseases, including catheters, stents, balloons, and other interventional devices, typically introduced into the body via minimally invasive procedures, aimed at improving blood flow, repairing vascular damage, or alleviating vascular stenosis.
Published: 2024-10-10
Pages: 103
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now